PMDA drug package insert
テブダック点滴静注用40mg
PMDA Prescription drug · ジェンマブ株式会社 · package insert May 21, 2025
Key facts
| Brand names | テブダック点滴静注用40mg |
|---|---|
| Nonproprietary names | チソツマブ ベドチン（遺伝子組換え） |
| Companies | 製造販売元／ジェンマブ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤／組織因子標的抗体微小管阻害薬複合体 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291479D1028 |
| Approval numbers | 30700AMX00085000 |
| Package insert edition | 第2版 |
| Package insert date | May 21, 2025 |
| PMDA document key | 343257_4291479D1028_1 |
| PMDA company code | 343257 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: